Teva must face government's kickback claims over Copaxone - judge [Reuters]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Reuters
Federal probe of drugmakers, charities has yielded more than $1 billion The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback, which you can provide using the feedback tab on the right of the page. (Reuters) - Israeli drugmaker Teva Pharmaceutical Industries Ltd must face a lawsuit by the U.S. government accusing it of using kickbacks paid through charitable foundations to boost sales of its multiple sclerosis drug Copaxone, resulting in false claims being submitted to Medicare. U.S. District Judge Nathaniel Gorton on Thursday denied Teva's motion to dismiss the case, rejecting its argument that its donations to the foundations could not violate the law because the company did not control how they were ultimately used. Teva and its attorneys Emily Renshaw and Eric Sitarchuk of Morgan, Lewis & Bockius did not immediately respond to re
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Physician Perspective on Generic Drugs Thematic Research Report 2024 [Yahoo! Finance]Yahoo! Finance
- Teva to Present at the 2024 Bank of America Healthcare ConferenceBusiness Wire
- Teva's 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets [Yahoo! Finance]Yahoo! Finance
- Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious TargetsBusiness Wire
TEVA
Earnings
- 1/31/24 - Beat
TEVA
Sec Filings
- 4/18/24 - Form 8-K
- 4/16/24 - Form DEFA14A
- 4/16/24 - Form ARS
- TEVA's page on the SEC website